Seth P. Lerner
Impact in
Papers in
- Co-authors
- Shahrokh François Shariat (70 shared papers)Yair Lotan (44 shared papers)Arthur I. Sagalowsky (35 shared papers)Pierre I. Karakiewicz (39 shared papers)Mark Schoenberg (36 shared papers)Patrick J. Bastian (29 shared papers)Ashish M. Kamat (24 shared papers)Ganesh S. Palapattu (21 shared papers)
- Journals
- The Journal of Urology (83 papers)European Urology (34 papers)Urologic Oncology Seminars and Original Investigations (21 papers)Urology (21 papers)Bladder Cancer (18 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Seth P. Lerner
364 papers receiving 23.0k citations
Seth P. Lerner's Hit Papers
Peers
Comparison fields: 5 of 162
- Surgery 16.3k
- Urology 2.0k
- Cancer Research 2.0k
- Oncology 3.5k
- Pulmonary and Respiratory Medicine 3.2k
Countries citing papers authored by Seth P. Lerner
This map shows the geographic impact of Seth P. Lerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth P. Lerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth P. Lerner more than expected).
Fields of papers citing papers by Seth P. Lerner
This network shows the impact of papers produced by Seth P. Lerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth P. Lerner. The network helps show where Seth P. Lerner may publish in the future.
Co-authors
The 25 scholars most cited alongside Seth P. Lerner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 373 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer Hit paper breakdown → | 2017 | 1931 |
| 2 | Bladder cancer Hit paper breakdown → | 2016 | 1137 |
| 3 | Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline Hit paper breakdown → | 2017 | 724 |
| 4 | Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy Hit paper breakdown → | 2017 | 632 |
| 5 | Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: A Contemporary Series From the Bladder Cancer Research Consortium Hit paper breakdown → | 2006 | 576 |
| 6 | Two molecular pathways to transitional cell carcinoma of the bladder. Hit paper breakdown → | 1994 | 521 |
| 7 | Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance Hit paper breakdown → | 2014 | 490 |
| 8 | Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System) Hit paper breakdown → | 2018 | 463 |
| 9 | Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer Hit paper breakdown → | 2018 | 357 |
| 10 | Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial Hit paper breakdown → | 2020 | 344 |
| 11 | Integrated Molecular Characterization of Testicular Germ Cell Tumors Hit paper breakdown → | 2018 | 338 |
| 12 | ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder Hit paper breakdown → | 2012 | 326 |
| 13 | Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC) Hit paper breakdown → | 2016 | 314 |
| 14 | 2006 | 291 | |
| 15 | Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors Hit paper breakdown → | 2023 | 289 |
| 16 | 2004 | 276 | |
| 17 | 2005 | 254 | |
| 18 | 2013 | 254 | |
| 19 | 1993 | 239 | |
| 20 | 2001 | 235 |
About Seth P. Lerner
Seth P. Lerner is a scholar working on Surgery, Urology, Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 373 papers that have together received 23.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (262 papers), Urinary and Genital Oncology Studies (89 papers), Urological Disorders and Treatments (30 papers), Epigenetics and DNA Methylation (20 papers), Renal cell carcinoma treatment (16 papers), Esophageal Cancer Research and Treatment (15 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Prostate Cancer Treatment and Research (10 papers). The work is most often cited by research in Surgery (16.3k citations), Urology (2.0k citations), Cancer Research (2.0k citations), Oncology (3.5k citations) and Pulmonary and Respiratory Medicine (3.2k citations). Seth P. Lerner has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Shahrokh François Shariat, Yair Lotan, Arthur I. Sagalowsky, Pierre I. Karakiewicz, Mark Schoenberg, Patrick J. Bastian, Ashish M. Kamat, Ganesh S. Palapattu, Amnon Vazina and Wassim Kassouf. Their work appears in journals such as The Journal of Urology, European Urology, Urologic Oncology Seminars and Original Investigations, Urology and Bladder Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.